Kupffer Cell Necroptosis and Homeostatic Function in Liver Immune Responses against Ischemia Reperfusion Injury
库普弗细胞坏死性凋亡和肝脏缺血再灌注损伤免疫反应中的稳态功能
基本信息
- 批准号:9167747
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-15 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-Inflammatory AgentsAnti-inflammatoryApoptoticCell DeathCell physiologyCellsClinicClinicalDataDichloromethylene DiphosphonateDimensionsDiseaseEmigrationsExcisionFoundationsFunctional disorderFutureHumanITGAM geneImmuneImmune responseIn VitroInfiltrationInflammationInflammatoryInflammatory InfiltrateInflammatory ResponseInjuryIschemiaKineticsKupffer CellsLiverMediatingModelingMolecularMusNecrosisOperative Surgical ProceduresOutcomePathogenesisPatternPattern recognition receptorPhagocytosisPlayProcessPublic HealthRecoveryReperfusion InjuryResearchResolutionRoleSeminalStagingTLR4 geneTestingTherapeuticTherapeutic InterventionTissuesTransplantationTraumaWarm Ischemiabasecell injurydesigndriving forceimmune activationimmune functionin vivoliver functionliver inflammationliver ischemiamacrophagemonocytenovelreceptorreconstitutionresearch studyresponsetargeted treatmenttumor
项目摘要
PROJECT SUMMARY
The overall object of our research in liver ischemia reperfusion injury (IRI) is to comprehend mechanisms of
inflammatory immune activation and resolution. In the last ten years, we have made significant progresses in
dissecting molecular mechanisms of liver innate immune response against IR. However, its cellular basis is
relatively less-well defined. Kupffer cells (KCs) are liver resident macrophages, which are highly
heterogeneous and evolving kinetically in disease processes. Their response against IR has not been fully
delineated, particularly in the context of recent finding that tissue resident and monocyte-derived infiltrating
macrophages are distinctive in their lineages and functions. Our recent analysis of KC/macrophage subsets in
IR livers reveals that liver inflammatory immune activation is associated with not only increases/activations of
infiltrating macrophages (iMØs), but also a drastic depletion of resident KCs (KCs). The opposite, i.e.,
contraction of iMØs and recovery of KCs, is associated with the resolution of liver inflammation. Additionally,
M1 polarization is evident in the activation stage, and M2 polarization in the resolution stage of liver immune
response in both liver macrophage subsets. The purpose of this exploratory project is to perform proof of
principle experiments to establish functional significance of KC depletion in liver IRI, and determine potential
mechanisms of KC homeostatic functions in livers against IR. We hypothesize that IR triggers KC
necroptosis which constitutes a key mechanism of liver inflammatory immune activation and functions
in synergy with the infiltration and activation of iMØs. Additionally, KCs execute the homeostatic
function in liver IRI by phagocytosis of apoptotic/necrotic cells, which regulates KC innate immune
activation and promotes their polarization towards immune regulatory/reparative type. We will test
these two hypothesis in two specific aims. Our study will be the first to analyze specifically responses and
functions of liver resident macrophages in IRI. Results will further our understanding of the disease
pathogenesis, and potentially provide novel rationale to design appropriate cell-targeted therapies to
ameliorate liver IRI.
项目摘要
我们在肝缺血再灌注损伤(IRI)研究的总体对象是理解机制
炎症免疫激活和分辨率。在过去的十年中,我们在
剖析肝脏先天免疫反应对IR的分子机制。但是,其细胞基础是
相对较小的定义。 kupffer细胞(KC)是肝居民巨噬细胞,这是高度的
在疾病过程中非均质和动力学发展。他们对IR的反应尚未完全
划定的,特别是在最近发现组织居民和单核细胞介绍的情况下
巨噬细胞在其谱系和功能中是独特的。我们最近对KC/巨噬细胞子集的分析
红外肝脏表明肝脏炎性免疫激活不仅与增加/激活有关
渗透巨噬细胞(IMøs),但也急剧耗尽了居民KCS(KCS)。相反,即
IMøs的收缩和KC的恢复与肝脏注射的分辨率有关。此外,
M1极化是激活阶段的证据,而M2极化在肝脏免疫的分辨率阶段
两种肝巨噬细胞子集的反应。这个探索项目的目的是执行
主要实验在肝脏IRI中建立KC耗竭的功能意义,并确定潜力
肝脏对IR的KC稳态功能的机制。我们假设IR触发KC
坏死性构成肝脏炎性免疫激活和功能的关键机制
与IMøs的渗透和激活协同作用。此外,KCS执行体内平衡
通过凋亡/坏死细胞的吞噬作用在肝脏IRI中的功能,该细胞调节KC先天免疫
激活并促进其对免疫调节/修复类型的极化。我们将测试
这两个假设在两个具体目标中。我们的研究将是第一个分析特别响应的研究
IRI中肝居民巨噬细胞的功能。结果将进一步我们对疾病的理解
发病机理,并有可能为设计适当的细胞靶向疗法设计为新颖的理由
改善肝脏IRI。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YUAN ZHAI其他文献
YUAN ZHAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YUAN ZHAI', 18)}}的其他基金
Glycogen Synthase Kinase 3 beta in liver ischemia reperfusion injury
糖原合酶激酶3β在肝脏缺血再灌注损伤中的作用
- 批准号:
10721921 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Glycogen Synthase Kinase 3 beta in liver ischemia reperfusion injury
糖原合酶激酶3β在肝脏缺血再灌注损伤中的作用
- 批准号:
10348751 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别:
Glycogen Synthase Kinase 3 beta in liver ischemia reperfusion injury
糖原合酶激酶3β在肝脏缺血再灌注损伤中的作用
- 批准号:
10153767 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别:
Regulation of Innate Immune Responses by Alloimmunity in Liver Ischemia-Reperfusion Injury
肝脏缺血再灌注损伤中同种免疫对先天免疫反应的调节
- 批准号:
9975699 - 财政年份:2017
- 资助金额:
$ 23.1万 - 项目类别:
Inflammation Resolution in Liver Ischemia-Reperfusion Injury
肝脏缺血再灌注损伤的炎症消退
- 批准号:
10622472 - 财政年份:2017
- 资助金额:
$ 23.1万 - 项目类别:
Inflammation Resolution in Liver Ischemia-Reperfusion Injury
肝脏缺血再灌注损伤的炎症消退
- 批准号:
10328214 - 财政年份:2017
- 资助金额:
$ 23.1万 - 项目类别:
CXCL10/CXCR3 Signaling Regulates TLR4-Mediated Liver Inflamation and Injury
CXCL10/CXCR3 信号传导调节 TLR4 介导的肝脏炎症和损伤
- 批准号:
7782845 - 财政年份:2010
- 资助金额:
$ 23.1万 - 项目类别:
CXCL10/CXCR3 Signaling Regulates TLR4-Mediated Liver Inflamation and Injury
CXCL10/CXCR3 信号传导调节 TLR4 介导的肝脏炎症和损伤
- 批准号:
8050656 - 财政年份:2010
- 资助金额:
$ 23.1万 - 项目类别:
CXCL10/CXCR3 Signaling Regulates TLR4-Mediated Liver Inflamation and Injury
CXCL10/CXCR3 信号传导调节 TLR4 介导的肝脏炎症和损伤
- 批准号:
8434152 - 财政年份:2010
- 资助金额:
$ 23.1万 - 项目类别:
CXCL10/CXCR3 Signaling Regulates TLR4-Mediated Liver Inflamation and Injury
CXCL10/CXCR3 信号传导调节 TLR4 介导的肝脏炎症和损伤
- 批准号:
8616058 - 财政年份:2010
- 资助金额:
$ 23.1万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
卵巢癌中的歧视、生态失调和种族差异的经历
- 批准号:
10371537 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别: